LYMPHOMATOID PAPULOSIS
Clinical trials for LYMPHOMATOID PAPULOSIS explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMATOID PAPULOSIS trials appear
Sign up with your email to follow new studies for LYMPHOMATOID PAPULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted therapy tested for Hard-to-Treat skin cancers
Disease control OngoingThis study tested whether the drug brentuximab vedotin could help control three types of CD30-positive skin lymphomas in patients whose disease had come back or did not respond to prior treatments. The drug is designed to find and enter cancer cells with a specific marker (CD30) …
Matched conditions: LYMPHOMATOID PAPULOSIS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Supercharged immune cells take aim at tough lymphomas in groundbreaking trial
Disease control OngoingThis study is testing a new type of personalized cell therapy for adults whose CD30+ lymphomas have come back or not responded to standard treatments. Doctors take a patient's own immune cells (T cells), genetically modify them to better find and attack cancer cells, and then inf…
Matched conditions: LYMPHOMATOID PAPULOSIS
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC